Preventive surgeries could benefit at-risk women

08/31/2010 | HealthDay News

U.S. researchers found that women with mutations in the BRCA1 or BRCA2 genes that increase the risk of breast and ovarian cancer had a 70% to 80% lower risk of dying of the diseases after undergoing preventive mastectomy or having their ovaries and fallopian tubes removed. The study showed that women who underwent mastectomies had no breast cancer during the follow-up period, compared with a diagnosis of breast cancer in 7% of women who didn't have surgery.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA